ReviewJournal of spine surgery (Hong Kong)2026
The renewed role of interspinous devices: the InSpan system-a narrative review on surgical indications.
Review in Journal of spine surgery (Hong Kong), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Revision surgical technique for laterally placed MinuteManJournal of spine surgery (Hong Kong) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: Interspinous devices have evolved from simple distraction spacers to interlaminar fixation systems capable of promoting fusion and stability. Early distraction-only implants were associated with high failure and reoperation rates, leading surgeons to abandon this technology. The InSpan system represents a new generation of posterior, interlaminar fixation devices designed to provide indirect decompression and interlaminar fusion. The goal of this review is to define practical, evidence-based indications and contraindications for the InSpan system within the context of interlaminar fixation, and to position this strategy among decompression alone and pedicle-based fusions. Methods: This narrative review synthesizes evidence on interspinous and interlaminar fixation devices, with focus on the InSpan system. A search of PubMed/MEDLINE, Embase, and Cochrane Library databases up to November 2025 using the MeSH terms "interspinous device", "interlaminar fixation", "InSpan", "lumbar spinal stenosis", "spondylolisthesis", and "disc herniation" identified studies evaluating device design, kinematic behavior, clinical outcomes, and complications. Emphasis was placed on data informing practical surgical indications, contraindications, and patient selection criteria for InSpan. Key Content and Findings: Available biomechanical studies suggest that InSpan provides meaningful flexion-extension control and serves as an effective scaffold for interlaminar fusion, while avoiding pedicle violation and preserving the posterior structures. Clinical series report sustained improvements in pain and disability scores, low revision and complication rates, and radiographic evidence of fusion in selected patients. The most promising indications include: (I) recurrent lumbar disc herniation after microdiscectomy with segmental micromotion or disc height loss; (II) single-level lumbar spinal stenosis with low-grade spondylolisthesis or mild instability in patients at elevated risk for pedicle-screw fusion; and (III) foraminal or far-lateral stenosis where preservation of foraminal height is critical. Severe instability, high-grade spondylolisthesis, deformity, and multilevel disease remain better suited to conventional fusion constructs. Conclusions: Interlaminar fixation devices appear to occupy a valuable niche between decompression alone and pedicle-based fusion, particularly in single-level degenerative pathology and fragile patients. When combined with decompression, InSpan can provide indirect decompression and interlaminar fusion with reduced surgical morbidity. Nevertheless, current evidence is largely limited, and high-quality randomized and long-term studies are needed to refine indications, durability, and cost-effectiveness.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.